Cipla Ltd. Reaches All-Time High Stock Price, Receives 'Buy' Call from MarketsMOJO
Cipla Ltd., a leading pharmaceutical company in India, has reached an all-time high stock price of Rs. 1681.05 on September 2nd, 2024. This is a significant milestone for the company, reflecting its strong performance and growth in the industry. With a 'Buy' call from MarketsMojo and consistent gains in the market, Cipla's stock is a promising investment option in the pharma sector.
Cipla Ltd., a leading pharmaceutical company in India, has recently reached an all-time high stock price of Rs. 1681.05 on September 2nd, 2024. This is a significant milestone for the company, showcasing its strong performance and growth in the industry.
MarketsMOJO, a renowned stock market analysis and research firm, has given a 'Buy' call for Cipla's stock. This further reinforces the positive sentiment around the company's stock and its potential for future growth.
Cipla's stock has been performing well in the market, with a consecutive gain for the last 2 days and a 2.58% increase in returns during this period. The stock is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend.
In comparison to the overall market performance, Cipla has outperformed the Sensex with a 1-year return of 32.44% as opposed to Sensex's 26.21%. This showcases the company's strong financials and its ability to generate value for its investors.
Cipla's success can be attributed to its strong presence in the pharmaceutical industry, with a wide range of products and a focus on innovation and quality. With its consistent growth and positive outlook, Cipla is a promising investment option for those looking to invest in the pharma sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
